September is recognized as Prostate Cancer Awareness Month, aimed at raising awareness about one of the most common cancers affecting men globally. While prostate cancer typically develops in older ...
INmune Bio's initial results from cohort 1 of the phase I/II CaRe PC trial, using INKmune for the treatment of patients with mCRPC released. Read why INMB is a Buy.
Each year, the Philippines records approximately 150,000 new cancer cases, presenting a significant financial challenge for patients and their families. For those unable to afford treatment, the ...
Partow Kebriaei, MD, discusses what factors may influence the decision for transplant in patients with acute lymphoblastic leukemia and how experts determine who is best fit for transplant.